QIBK:QSEQatar Islamic Bank Analysis
Data as of 2026-03-13 - not real-time
QAR 22.58
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Qatar Islamic Bank trades at QAR 22.58, delivering a trailing P/E of about 11.6, well below the regional banking average of 16.4, suggesting a valuation discount. The stock offers a dividend yield near 4% with a payout ratio under 50%, making it attractive for income‑focused investors. Technical signals are mixed: the 20‑day SMA (23.91) sits above the current price, the RSI at 35 points to modest oversold pressure, while the MACD remains bearish and the overall trend is neutral. Support around QAR 21.80 provides a floor, and the price is still 15% below the analyst mean target of 25.99, indicating upside potential. However, operating cash flow is negative and volatility over the past month exceeds 26%, which tempers enthusiasm.
Given the low beta (≈0.3) and increasing volume, liquidity risk is limited, but the concentration in a single Gulf market adds geographic exposure. The bank’s strong capital base (price‑to‑book 1.8) and solid profit margin (≈43%) support the dividend, yet the recent –5% revenue contraction raises questions about sustainable growth. In a market environment characterized by a “Greed” sentiment index of 72.7, the stock appears fairly priced on a value basis with a modest upside, making a cautious buy stance appropriate for medium horizons while a hold is prudent in the short run.
Given the low beta (≈0.3) and increasing volume, liquidity risk is limited, but the concentration in a single Gulf market adds geographic exposure. The bank’s strong capital base (price‑to‑book 1.8) and solid profit margin (≈43%) support the dividend, yet the recent –5% revenue contraction raises questions about sustainable growth. In a market environment characterized by a “Greed” sentiment index of 72.7, the stock appears fairly priced on a value basis with a modest upside, making a cautious buy stance appropriate for medium horizons while a hold is prudent in the short run.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near support level
- moderate oversold RSI
- high dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- valuation discount to peers
- upside potential to analyst target
- stable profit margins
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- sustainable dividend income
- negative operating cash flow
- limited growth prospects
Key Metrics & Analysis
Financial Health
Revenue Growth-5.00%
Profit Margin43.29%
P/E Ratio11.6
ROE14.74%
ROA2.29%
P/B Ratio1.8
Op. Cash FlowQAR-2077851008
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI35.7
SupportQAR 21.80
ResistanceQAR 25.49
MA 20QAR 23.91
MA 50QAR 24.40
MA 200QAR 23.84
MACDBearish
VolumeIncreasing
Fear & Greed Index72.66
Valuation
Target PriceQAR 25.99
Upside/Downside15.08%
GradeUndervalued
TypeValue
Dividend Yield3.99%
Risk Assessment
Beta0.26
Volatility26.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.